Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma-a case report

被引：1
|
作者：
Leven, Anna-Sophia [1 ]
Becker, Juergen C. [2 ,3 ]
Poettgen, Christoph [4 ]
Schadendorf, Dirk [1 ,5 ,6 ,7 ]
Ugurel, Selma [1 ,5 ,6 ,7 ]
Tasdogan, Alpaslan [1 ,5 ,6 ,7 ]
机构：
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol Venereol & Allergol, Essen, Germany
[2] Univ Med, Translat Skin Canc Res, Essen, Germany
[3] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Heidelberg, Germany
[4] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Radiotherapy, Essen, Germany
[5] German Canc Consortium, Partner Site Essen, Essen, Germany
[6] Univ Duisburg Essen, Natl Ctr Tumor Dis NCT West, Campus Essen, Essen, Germany
[7] Univ Duisburg Essen, Res Ctr One Hlth, Res Alliance Ruhr, Essen, Germany
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年 / 63卷 / 02期
关键词：
OPEN-LABEL;
D O I：
10.1111/ijd.16986
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e69 / e71
页数：3
相关论文
共 50 条
  • [21] Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
    Alden, Stephanie L.
    Lim, Mir
    Kao, Chester
    Shu, Daniel
    Singal, Amit G.
    Noonan, Anne
    Griffith, Paige
    Baretti, Marina
    Ho, Won Jin
    Kamel, Ihab
    Yarchoan, Mark
    Hsiehchen, David
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (07): : 1312 - 1317
  • [22] PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma
    Gaiser, Maria Rita
    Bongiorno, Michelle
    Brownell, Isaac
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 345 - 359
  • [23] Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases
    Knackstedt, R.
    Sussman, T. A.
    McCahon, L.
    Song, J. -M.
    Funchain, P.
    Gastman, B.
    ANNALS OF ONCOLOGY, 2019, 30 (08) : 1399 - 1400
  • [24] Biomarkers of response to PD-1 inhibition in Merkel cell carcinoma
    Spassova, I
    Ugurel, S.
    Kubat, L.
    Terheyden, P.
    Hassel, J.
    Schadendorf, D.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 5 - 5
  • [25] PD-1 blockade with pembrolizumab in advanced Merkel cell carcinoma
    Ziemer, Mirjana
    ONKOLOGE, 2016, 22 (10): : 790 - 792
  • [26] PD-1-and PD-L1-Expression in Merkel Cell Carcinoma
    Wehkamp, U.
    Stern, S.
    Krueger, S.
    Roecken, C.
    Egberts, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 5 - 5
  • [27] PD-1 inhibition in advanced Merkel-cell carcinoma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (06): : E225 - E225
  • [28] The future of immunotherapy in advanced renal cell carcinoma: beyond PD-1/PD-L1 inhibitors
    Nuvola, Giacomo
    Mollica, Veronica
    Massari, Francesco
    Suarez, Cristina
    IMMUNOTHERAPY, 2023, 15 (17)
  • [29] Merkel polyomavirus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma
    Veatch, Joshua
    Paulson, Kelly
    Asano, Yuta
    McAfee, Megan
    Martin, Lauren
    Lee, Bo
    Hall, Evan
    Bhatia, Shailender
    Nghiem, Paul
    Chapuis, Aude
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (10) : 2840 - 2840
  • [30] PD-1 blockade and T cell responses in merkel cell carcinoma
    Miller, N. J.
    Church, C.
    Fling, S.
    Kulikauskas, R.
    Ramchurren, N.
    Shinohara, M.
    Cheever, M.
    Topalian, S. L.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S45 - S45
12345